Brean Capital Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold
Tweet Send to a Friend
Brean Capital downgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from Buy to Hold following yesterday's 31% surge on strong Phase 3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
